...
首页> 外文期刊>Monatshefte fur Chemie >Antineoplastic activity of fused nitrogen-phosphorus heterocycles and derived phosphonates
【24h】

Antineoplastic activity of fused nitrogen-phosphorus heterocycles and derived phosphonates

机译:稠合的氮磷杂环化合物和衍生的膦酸酯的抗肿瘤活性

获取原文
获取原文并翻译 | 示例

摘要

A variety of derivatives incorporating substituted heterocycle-phosphor motifs is described. Substituted N,P-heterocycles and derived phosphonates were produced efficiently in a tandem operation without intermediate isolation. The synthesis methodology is based on the reaction of dialkyl phosphites with Schiff base Kabachnik-Fields intermediates, which are generated in situ from 2-amino-4,6-di-tert-butylphenol and substituted benzaldehydes in dry THF/FeCl3 (10 %) solution, to yield fused oxazole-2-phosphonates in moderate yield (≈55 %). The latter products could be also obtained in excellent yield (≥76 %) by directly applying the same P(III) reagents to the parent Schiff bases. On the other hand, oxazaphosphinine-2-amines were isolated in high yields (≈77 %) when the Schiff bases were allowed to react with hexaalk-yltriamidophosphites at rt. More P-heterocycles and the derived phosphonates were also obtained when the same reagents were applied to another imino derivative derived from the aminophenol, 2-hydroxybenzaldehyde oxime. The synthesized scaffolds were biologically evaluated and found to possess potent anticancer activities. On the basis of bioassay data, the produced N,P-heterocycles exhibit remarkable antitumor activity against 17 tested human tumor cell lines, representing breast and prostate cancer and melanoma. Several phosphonates were found to possess specific anti-breast cancer activity (especially MDA-MB-435 cell lines) while others possess specific effects against melanoma (MI4 and SK-MEL-2 cancer cell lines). These findings form a foundation for further investigation in our continuing efforts to develop selective anticancer agents.
机译:描述了多种并入有取代的杂环-磷基团的衍生物。取代N,P-杂环和衍生的膦酸酯可通过串联操作高效生产,而无需中间分离。合成方法基于亚磷酸二烷基酯与席夫碱Kabachnik-Fields中间体的反应,该中间体由2-氨基-4,6-二叔丁基苯酚和取代的苯甲醛在干燥的THF / FeCl3(10%)中原位生成溶液,以中等产率(≈55%)产生稠合的恶唑-2-膦酸酯。通过直接将相同的P(III)试剂应用于母体Schiff碱,也可以以极好的收率(≥76%)获得后一种产品。另一方面,当允许席夫碱在室温下与六烷酰基三酰胺基亚磷酸酯反应时,草酸次氮膦-2-胺的分离产率很高(约77%)。当将相同的试剂应用于另一种衍生自氨基酚2-羟基苯甲醛肟的亚氨基衍生物时,还会获得更多的P-杂环和衍生的膦酸酯。对合成的支架进行了生物学评估,发现具有强大的抗癌活性。根据生物测定数据,所产生的N,P-杂环化合物对17种经测试的人类肿瘤细胞系表现出显着的抗肿瘤活性,这些细胞系代表乳腺癌和前列腺癌以及黑色素瘤。发现几种膦酸酯具有特定的抗乳腺癌活性(尤其是MDA-MB-435细胞系),而另一些具有针对黑素瘤的特定作用(MI4和SK-MEL-2癌细胞系)。这些发现为我们进一步努力开发选择性抗癌药奠定了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号